| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 73.525 | 1.656.610 | 300.966 | 801.268 | 585.319 | 307.689 | 80.459 | 5.661 | 0 |
| Total Income - EUR | - | 73.525 | 1.670.678 | 302.689 | 805.179 | 588.684 | 324.924 | 101.415 | 5.661 | 0 |
| Total Expenses - EUR | - | 69.576 | 1.607.521 | 302.461 | 787.341 | 588.525 | 321.389 | 115.544 | 18.936 | 11.258 |
| Gross Profit/Loss - EUR | - | 3.949 | 63.156 | 228 | 17.838 | 159 | 3.535 | -14.128 | -13.275 | -11.258 |
| Net Profit/Loss - EUR | - | 3.214 | 53.554 | 228 | 14.175 | -14.000 | 1.654 | -14.128 | -13.275 | -11.258 |
| Employees | - | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Bio-Nuc Trade Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 272 | 0 | 1 | 1.617 | 25.392 | 18.992 | 12.964 | 6.856 | 1.279 |
| Current Assets | - | 24.996 | 89.034 | 149.446 | 297.898 | 280.462 | 267.475 | 223.785 | 216.280 | 212.312 |
| Inventories | - | 0 | 1.843 | 34.641 | 12.138 | 5.025 | 6.735 | 75.111 | 72.775 | 72.368 |
| Receivables | - | 10.510 | 361 | 97.111 | 267.472 | 157.095 | 170.733 | 125.033 | 100.997 | 138.629 |
| Cash | - | 14.485 | 86.830 | 17.694 | 18.287 | 118.342 | 90.007 | 23.641 | 42.508 | 1.316 |
| Shareholders Funds | - | 3.258 | 56.758 | 55.966 | 69.057 | 157.115 | 164.862 | 151.245 | 137.511 | 125.484 |
| Social Capital | - | 45 | 44 | 64 | 63 | 103.430 | 101.136 | 101.450 | 101.142 | 100.577 |
| Debts | - | 22.009 | 32.276 | 93.481 | 230.458 | 148.739 | 121.605 | 85.504 | 85.625 | 88.107 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4631 - 4631" | |||||||||
| CAEN Financial Year |
4631
|
|||||||||
Comments - Bio-Nuc Trade Srl